China Yet To Approve Merck, GSK HPV Vaccines As Concerns Rise
This article was originally published in PharmAsia News
Executive Summary
China’s drug authority has yet to approve HPV vaccines such as Gardasil, made by Merck, and Cervarix, by GlaxoSmithKline, already available in more than 100 nations and regions.